top of page
image_edited.jpg

Clinical Decision Analytics

Retinal imaging and AI platform that supports faster and more effective diagnosis and management of patients with Age-Related Macular Degeneration    

Age-Related Macular Degeneration is the leading cause of vision loss for people 50 years of age and older.  

The global health impact and cost of undiagnosed and untreated AMD is severe,  

and it's only getting worse.  

300 MILLION 

Estimated number of people who will experience moderate to severe vision loss because of AMD by 2040.

Annual Direct Healthcare Costs

$100 Billion US

$343 Billion globally

We believe the devastating health impacts of AMD can be significantly reduced, and even prevented, with a better approach to early-stage detection and risk monitoring

Optina's AI-Driven Clinical Decision Support

Preserving Vision 

We combine our FDA 510(k) cleared hyperspectral camera with leading AI capabilities to enable eye specialists to more accurately diagnose and manage early, intermediate and late-stage retinal disease, including monitoring therapeutic effectiveness in at-risk patients. 

Key Capabilities

couple dancing.webp

DETECT

The onset of early and intermediate stage retinal disease feature more accurately with a ~1-second scan

IDENTIFY

Which patients are at high risk of vision impairment, before any loss occurs 

MONITOR

The growth, development and position of key retinal pathologies that indicate disease progression

ENABLE

A patient-centric approach to enable rapid detection, decision-support and access to time-sensitive interventions

Contact us

Contact:

 

Optina

8200 Decarie Blvd, Suite 220

Montreal, QC H4P 2P5, Canada

support@optinadx.com

@2025 Optina

All Rights Reserved

bottom of page